1. Home
  2. AAT vs HROW Comparison

AAT vs HROW Comparison

Compare AAT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$25.31

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$42.30

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
HROW
Founded
1967
1998
Country
United States
United States
Employees
208
373
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AAT
HROW
Price
$25.31
$42.30
Analyst Decision
Sell
Strong Buy
Analyst Count
2
8
Target Price
$19.50
$69.86
AVG Volume (30 Days)
455.3K
836.4K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
6.65%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$436,204,000.00
N/A
Revenue This Year
$4.33
$31.62
Revenue Next Year
$0.22
$50.77
P/E Ratio
$315.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$28.54
52 Week High
$25.34
$54.98

Technical Indicators

Market Signals
Indicator
AAT
HROW
Relative Strength Index (RSI) 70.84 62.53
Support Level $18.23 $40.61
Resistance Level N/A $44.50
Average True Range (ATR) 0.49 2.09
MACD -0.02 0.21
Stochastic Oscillator 88.95 64.24

Price Performance

Historical Comparison
AAT
HROW

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: